Skip to main content
. Author manuscript; available in PMC: 2013 Jul 15.
Published in final edited form as: Mol Pharm. 2011 Nov 15;8(6):2444–2453. doi: 10.1021/mp200401p

Table 3.

Tumor-to-muscle ratios derived from the biodistribution studies.

compound tumor-to-
muscle ratio
Relative ratio compared
to compound 11
Ac-TZ14011-DTPA (11) 6.67 ± 0.66 1
monomer Ac-TZ14011-MSAP (3) 4.55 ± 0.68* 0.68
dimer (Ac-TZ14011)2-MSAP (7) 7.41 ± 1.87 1.11
tetramer (Ac-TZ14011)4-MSAP (10) 5.47 ± 0.50 0.82
*

P < 0.05 for the comparison of compound 3 with 11.